Subtotal $0.00
Shop Now
Are peptides safe? There is no single answer, because “peptide” covers everything from insulin and GLP-1 medicines to collagen powder, skin creams and unapproved compounds sold online. FDA-approved peptide drugs have known, labeled side effects that were studied in clinical trials. Collagen peptides are a food-derived protein that trials report as generally well tolerated. Cosmetic peptides are not approved before sale but must meet safety rules. Unapproved “research” peptides are the least understood: their purity, sterility and effects in people are largely unknown, and the FDA has raised specific concerns. This guide walks through each category.
Key Takeaways
- Safety depends on which peptide it is, who made it and how it is used.
- Approved peptide drugs have documented side effects, such as nausea with GLP-1 medicines and low blood sugar with insulin.
- A review of 11 trials with 805 people reported no adverse events from collagen supplements.
- The FDA does not approve cosmetics before sale, but companies must report serious reactions.
- Unapproved research peptides lack human safety data and are not checked for purity or sterility.
Why are peptides safe for some uses and risky for others?
Peptides are short chains of amino acids (see what peptides are). The chain itself does not make something safe or unsafe. What matters is the specific molecule, whether it has been tested in people, how it is made and whether a regulator has reviewed it. A peptide approved after large trials and made in an inspected factory is a very different product from an unlabeled vial of an untested compound, even if both are called peptides.
FDA-approved peptide drugs: known, labeled side effects
Dozens of approved medicines are peptides, including insulin, GLP-1 medicines such as semaglutide and tirzepatide, and tesamorelin. Their risks are well described because they went through clinical trials and the FDA requires them on the label.
- GLP-1 medicines: the Wegovy label lists nausea, diarrhea, vomiting, constipation and abdominal pain among the most common side effects. It carries a boxed warning about thyroid C-cell tumors seen in rodents and warns about pancreatitis, gallbladder disease, kidney injury from dehydration and low blood sugar when combined with insulin. Our GLP-1 guide covers this drug class.
- Insulin: insulin labels state that low blood sugar (hypoglycemia) is the most common adverse reaction and that severe hypoglycemia can cause seizures and may be life-threatening. They also warn about low potassium.
- Growth hormone-axis drugs: the somatropin and tesamorelin labels warn about fluid retention, glucose intolerance and tumor risk, among other effects.
Known risks can be weighed against benefits by a prescriber who knows your history. That is the main safety advantage of an approved drug: the side effects are counted, labeled and monitored. Compounded versions are not FDA-approved, and the FDA has received reports of patients and clinicians measuring or calculating the wrong amount of compounded GLP-1 products, some needing hospital care. See our guide to compounded semaglutide and tirzepatide.
Collagen and other supplement peptides
Collagen peptides (hydrolyzed collagen) are made by breaking down collagen from animal skin, hide or fish into small fragments. They are sold as dietary supplements and food ingredients. A 2019 systematic review in the Journal of Drugs in Dermatology examined 11 randomized trials with 805 participants and reported that collagen supplementation was generally safe, with no reported adverse events.
Two cautions apply. The FDA does not review supplements for safety or effectiveness before they are sold, so quality depends on the manufacturer. And marine collagen comes from fish, one of the major food allergens that U.S. labels must declare. Anyone who is pregnant, nursing or managing a health condition should follow the label and ask a healthcare provider.
Cosmetic peptides
Skin creams and serums often contain peptides, such as the copper peptide GHK-Cu. The FDA does not approve cosmetics before they are sold. Under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), companies must keep records supporting the safety of their products and report serious adverse events to the FDA within 15 business days. As with any cosmetic ingredient, some people may react with irritation or allergy.
The legal line depends on intended use. The FDA classifies a product meant to change the structure or function of the body as a drug, not a cosmetic, even if it is sold as skin care.
Unapproved and research peptides: the biggest unknowns
Compounds such as BPC-157, TB-500, CJC-1295 and ipamorelin, and investigational drugs such as retatrutide, are sold online with labels such as “for research” or “not for human consumption.” The concerns are specific:
- Little or no human data: most of these compounds have been studied mainly in cells and animals. For TB-500, the FDA said it found no human exposure data at all.
- Immunogenicity: in its compounding reviews, the FDA cited a possible risk of unwanted immune responses, partly because peptides can clump together.
- Impurities and identity: the FDA also cited peptide-related impurities. Nobody verifies that a research product contains what its label says.
- Sterility: in an August 2026 warning letter, the FDA said products given with a needle bypass some of the body’s key defenses against toxins and microorganisms.
- Reported harms: the FDA listed increased heart rate and a body-wide widening of blood vessels for CJC-1295, and serious adverse events including death in a published study of intravenous ipamorelin.
The regulatory picture changed in 2026, but not in a way that makes these products approved. The FDA removed 12 peptides, including BPC-157 and TB-500, from its Category 2 safety-risk list on April 15, 2026, after nominations were withdrawn. An advisory committee then voted in July 2026 to recommend six of them for compounding, against FDA staff advice. As of late September 2026, the FDA had not added any of them to the compounding list. Retatrutide remains an investigational drug; our retatrutide side effects guide summarizes its trial data. For the legal detail, read are peptides legal.
Peptide side effects at a glance
| Category | Examples | Reviewed before sale? | Known risks |
|---|---|---|---|
| FDA-approved peptide drugs | Insulin, semaglutide, tirzepatide, tesamorelin | Yes, FDA approval | Labeled side effects, e.g. GI effects, low blood sugar, boxed warnings |
| Compounded peptide drugs | Compounded semaglutide or tirzepatide | No | Same drug risks plus quality variation and measurement-error reports |
| Supplement peptides | Collagen peptides | No | Generally well tolerated in trials; fish allergen for marine collagen |
| Cosmetic peptides | GHK-Cu, palmitoyl peptides in skin care | No | Possible irritation or allergy; serious events must be reported |
| Unapproved research peptides | BPC-157, TB-500, CJC-1295, ipamorelin | No | Unknown human effects, immunogenicity, impurities, sterility concerns |
Questions to ask about any peptide
- Is this exact product FDA-approved for the use being described?
- Was it prescribed by a licensed clinician who knows your medical history?
- Is it dispensed by a licensed U.S. pharmacy, with a real label and patient information?
- What does the label or package insert say about side effects and who should not use it?
- If it is sold for research, has it ever been tested in people?
Honest answers to these questions sort most products quickly. For profiles of individual compounds and their regulatory status, see the Peptide Guide.
Frequently Asked Questions
Are peptides safe?
It depends on the peptide. Approved peptide drugs have known, labeled risks; collagen is generally well tolerated; unapproved research peptides have largely unknown safety.
What are common peptide side effects?
For approved drugs they are listed on the label, such as nausea and diarrhea with GLP-1 medicines or low blood sugar with insulin. For unapproved peptides, side effects have not been properly studied.
Are collagen peptides safe?
A review of 11 randomized trials with 805 people reported no adverse events. People with fish allergy should check the source of marine collagen.
Are research peptides safe to use?
Their safety in people is not established. The FDA has cited immune reactions, impurities and serious adverse events, and research products are not checked for sterility.
Did the FDA approve BPC-157 in 2026?
No. It was removed from the Category 2 list and later recommended by an advisory committee, but it is not FDA-approved and had not been added to the compounding list as of late September 2026.
Are peptide skin creams safe?
Cosmetics are not approved before sale, but companies must support their safety and report serious adverse events. Some people may react with irritation or allergy.
This article is general information, not medical or legal advice. Peptide Labs does not sell prescription, investigational or unapproved peptides, including any compound named here. Ask a licensed healthcare provider or pharmacist how this information applies to you.
Last reviewed September 2026.
Related guides: Are Peptides Legal? How U.S. Law Treats Each Type of Peptide, Peptides for Skin: Cosmetic Peptides, Copper Peptides and What Studies Show, HGH Peptides vs HGH: What Growth Hormone Peptides Really Are.